Selective Serotonin Reuptake Inhibitor Use in Primary Care: A 5-Year Naturalistic Study

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.16, Iss.6, 1998-12, pp. : 453-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement

By Poluzzi Elisabetta Motola Domenico Silvani Chiara Ponti Fabrizio Vaccheri Alberto Montanaro Nicola

European Journal of Clinical Pharmacology, Vol. 59, Iss. 11, 2004-01 ,pp. : 825-831

Springer Publishing Company

Access to resources Recommend Favorite

EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT 1A receptor agonistic properties

By Bartoszyk G.D. Hegenbart R. Ziegler H.

European Journal of Pharmacology, Vol. 322, Iss. 2, 1997-03 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

Catalepsy induced by the 5-HT 1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

By Eltayb A. Svensson T.H. Ahlenius S.

European Journal of Pharmacology, Vol. 411, Iss. 3, 2001-01 ,pp. : 275-277

Elsevier

Access to resources Recommend Favorite

Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression

By Griffiths R.I.

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 495-505

Adis International

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite